These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7515555)

  • 1. New use for alpha blockers: benign prostatic hyperplasia.
    Hill SJ; Lawrence SL; Lepor H
    Am Fam Physician; 1994 Jun; 49(8):1885-8, 1893-4. PubMed ID: 7515555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uroselectivity of alpha-1 antagonism in the treatment of benign prostatic hypertrophy: on the pharmacologic concept of the clinical approach].
    Jolliet P; Bourin M
    Therapie; 1998; 53(1):61-6. PubMed ID: 9773101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of benign prostatic hyperplasia with alpha receptor blockers].
    Stockamp K
    Urologe A; 1995 Jan; 34(1):3-8. PubMed ID: 7533449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Benign hypertrophy of the prostate: which treatment, for whom?].
    Schulman C
    Rev Med Brux; 1999 Sep; 20(4):A212-8. PubMed ID: 10523895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia.
    Caine M
    Urol Clin North Am; 1990 Aug; 17(3):641-9. PubMed ID: 1695784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [With alpha blockers, finasteride and nettle root against benign prostatic hyperplasia. Which patients are helped by conservative therapy?].
    Vahlensieck W
    MMW Fortschr Med; 2002 Apr; 144(16):33-6. PubMed ID: 12043098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological treatment of benign prostatic hyperplasia].
    Hansen J; Hald T
    Ugeskr Laeger; 1993 Dec; 155(50):4058-64. PubMed ID: 7505965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current drug therapy of benign prostatic hyperplasia].
    Schmidbauer CP; Madersbacher S
    Wien Med Wochenschr; 1996; 146(8):161-4. PubMed ID: 8767400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimising the medical management of benign prostatic hyperplasia.
    McDermott T
    Br J Clin Pract; 1997 Mar; 51(2):116-8. PubMed ID: 9158256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. alpha-blockade in the treatment of symptomatic benign prostatic hyperplasia.
    Eri LM; Tveter KJ
    J Urol; 1995 Sep; 154(3):923-34. PubMed ID: 7543612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.
    Agha AH; Roy JB; Culkin DJ; Lyon K
    Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review of the clinical efficacy and safety of 5alpha-reductase inhibitors for the enlarged prostate.
    Naslund MJ; Miner M
    Clin Ther; 2007 Jan; 29(1):17-25. PubMed ID: 17379044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the newer alpha, -adrenergic-receptor antagonists in the treatment of benign prostatic hyperplasia-related lower urinary tract symptoms.
    Lowe FC
    Clin Ther; 2004 Nov; 26(11):1701-13. PubMed ID: 15639685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical results with alpha-blockers in patients with symptomatic benign prostatic hyperplasia.
    Mensink HJ
    Prog Clin Biol Res; 1994; 386():285-9. PubMed ID: 7528396
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate cancer risk among users of finasteride and alpha-blockers - a population based case-control study.
    Murtola TJ; Tammela TL; Määttänen L; Hakama M; Auvinen A
    Eur J Cancer; 2007 Mar; 43(4):775-81. PubMed ID: 17251005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current treatment of BPH.
    Roylance P; Gibelin B; Espié J
    Biomed Pharmacother; 1995; 49(7-8):332-8. PubMed ID: 8562858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of alpha-blockers in the management of benign prostatic hyperplasia.
    Lowe FC; Stark E
    N Y State J Med; 1993 Mar; 93(3):169-73. PubMed ID: 7681155
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting.
    Keetch DW; Andriole GL; Ratliff TL; Catalona WJ
    Urology; 1997 Dec; 50(6):901-5. PubMed ID: 9426721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure.
    Dhaliwal AS; Habib G; Deswal A; Verduzco M; Souchek J; Ramasubbu K; Aguilar D; Ma TS; Jneid HM; Bolos M; Bozkurt B
    Am J Cardiol; 2009 Jul; 104(2):270-5. PubMed ID: 19576359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does benign prostatic hyperplasia treatment with alpha-blockers affect prostate cancer risk?
    Loeb S; Gupta A; Losonczy L; Tosoian J; Walsh PC
    Curr Opin Urol; 2013 Jan; 23(1):2-4. PubMed ID: 23159990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.